Register to chat with like-minded investors on our interactive forums.
The current CLCS market cap is 21.73M. The company's latest EPS is USD -0.1507 and P/E is -3.32.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.81M | -3.64M | -4.02M | -4.18M | -4.18M |
| Net Income | -5.22M | -5.44M | -6.45M | -6.33M | -6.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 115k | 452k | 314k | 410k | 195k |
| Total Liabilities | 5.86M | 8.4M | 10.14M | 13.04M | 15.81M |
| Total Equity | -5.74M | -7.95M | -9.83M | -12.63M | -15.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.59M | -2.78M | -3.38M | -3.14M | -2.35M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.6M | 2.99M | 3.23M | 3.27M | 2.15M |
| Market Cap | 21.73M |
| Price to Earnings Ratio | -3.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1,000 |
| Price to Book Ratio | -1.39 |
| Dividend Yield | - |
| Shares Outstanding | 43.47M |
| Average Volume (1 week) | 8.74k |
| Average Volume (1 Month) | 17k |
| 52 Week Change | 11.11% |
| 52 Week High | 0.75 |
| 52 Week Low | 0.0002 |
| Spread (Intraday) | 0.22 (37.81%) |
| Company Name | Cell Source Inc (QB) |
| Address |
701 s carson street carson city, nevada 89701 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
